These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11014244)

  • 1. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.
    Rocha R; Stier CT; Kifor I; Ochoa-Maya MR; Rennke HG; Williams GH; Adler GK
    Endocrinology; 2000 Oct; 141(10):3871-8. PubMed ID: 11014244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
    Oestreicher EM; Martinez-Vasquez D; Stone JR; Jonasson L; Roubsanthisuk W; Mukasa K; Adler GK
    Circulation; 2003 Nov; 108(20):2517-23. PubMed ID: 14581407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
    Rocha R; Martin-Berger CL; Yang P; Scherrer R; Delyani J; McMahon E
    Endocrinology; 2002 Dec; 143(12):4828-36. PubMed ID: 12446610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
    Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T
    Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.
    Martinez DV; Rocha R; Matsumura M; Oestreicher E; Ochoa-Maya M; Roubsanthisuk W; Williams GH; Adler GK
    Hypertension; 2002 Feb; 39(2 Pt 2):614-8. PubMed ID: 11882618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland.
    Usui M; Ichiki T; Katoh M; Egashira K; Takeshita A
    Hypertension; 1998 Sep; 32(3):527-33. PubMed ID: 9740621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
    Zhou X; Ono H; Ono Y; Frohlich ED
    Am J Nephrol; 2004; 24(2):242-9. PubMed ID: 15031627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II.
    Oestreicher EM; Guo C; Seely EW; Kikuchi T; Martinez-Vasquez D; Jonasson L; Yao T; Burr D; Mayoral S; Roubsanthisuk W; Ricchiuti V; Adler GK
    Kidney Int; 2006 Nov; 70(10):1759-68. PubMed ID: 17021606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Janus effect: two faces of aldosterone.
    Brem AS
    Kidney Int; 2009 Jan; 75(2):137-9. PubMed ID: 19116642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
    Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
    J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.
    Blasi ER; Rocha R; Rudolph AE; Blomme EA; Polly ML; McMahon EG
    Kidney Int; 2003 May; 63(5):1791-800. PubMed ID: 12675855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.
    Wangensteen R; O'Valle F; Del Moral R; Vargas F; Osuna A
    Med Sci Monit; 2002 Sep; 8(9):BR378-84. PubMed ID: 12221376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
    Helle F; Jouzel C; Chadjichristos C; Placier S; Flamant M; Guerrot D; François H; Dussaule JC; Chatziantoniou C
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F191-9. PubMed ID: 19420116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.